2648650-50-2
Chemical Structure
Vasopressin V2 receptor antagonist 1
- CAS. Nr.: 2648650-50-2
- Formula:C33H37ClN4O4
- Molecular Weight:589.12
IUPAC Name: N-(4-((2-(cyclopropanecarboxamido)pyridin-4-yl)oxy)-3-fluorophenyl)-4-methyl-3,5-dioxo-2-phenyl-2,3,4,5-tetrahydro-1,2,4-triazine-6-carboxamide
InChIKey: CEPCBRWQBCKEPG-UHFFFAOYSA-N
SMILES: ClC1=CC2=C(C=C1)N(C(C3=C(C=C(C=C3)NC(C4=C(C=CC=C4)C)=O)C)=O)CCCC2NCCC(N5CCOCC5)=O
Biological Activity: Vasopressin V2 receptor antagonist 1 is a vasopressin V2 receptor (V2R) antagonist with a Ki value of 3.8 nM. Vasopressin V2 receptor antagonist 1 inhibits renal cyst formation in embryonic renal cyst models and mouse models. Vasopressin V2 receptor antagonist 1 can be used in research related to autosomal dominant polycystic kidney disease[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Vasopressin V2 receptor antagonist 1 | Vasopressin V2 receptor antagonist 1 is a vasopressin V2 receptor (V2R) antagonist with a Ki value of 3.8 nM. Vasopressin V2 receptor antagonist 1 inhibits renal cyst formation in embryonic renal cyst models and mouse models. Vasopressin V2 receptor antagonist 1 can be used in research related to autosomal dominant polycystic kidney disease. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
